Statins & Dementia - The STAREE Trial
This very large 10,000 participant randomized trial (STAREE) is finished now. The data is being analyzed. They are going to report results in just a few months.
We are finally going to get a solid answer on whether or not statins protect against dementia in older people.
In the mean time, there is something we can immediately learn from this trial…
If there was any major signal of harm, the trial would have been stopped early. That has obviously not occurred.
On the flip side, if the results were spectacular, it would also have been stopped early. That didn’t happen either.
The implication of this is that the results are likely somewhere in between: No major harm from 40mg atorvastatin when it comes to dementia, but also no spectacular benefit.
We will have to wait a few more months to find out the exact results… stay tuned.
I can promise you that we are going to be talking a lot about this trial when it finally reports, regardless of the results. There has never been a statin trial like this before. It addresses MANY unanswered questions, especially about how statins affect development of common neurological diseases as people get older, like Alzheimer’s, Lewy Body Dementia, Parkinson’s, etc. This trial is a big deal.
Do statins extend lifespan of the elderly?
Do they protect against dementia, cognitive decline, and cardiovascular disease in people over 70?
We will soon have a definitive answer.
The STAREE trial (Statins in Reducing Events in the Elderly) is a very large randomized, placebo-controlled study investigating whether starting statins (atorvastatin 40mg) in 10,000 healthy adults aged 70+ prolongs independent, disability-free survival. They are particularly emphasizing disability-free survival which includes absence of dementia.
monash.eduLink to monash.edumonash.edu
Conducted across Australia, the trial specifically examines the effects of statins on preventing dementia, cognitive decline, and cardiovascular disease in healthy older people.
The trial is complete. They are analyzing the data right now. Results will be reported in just a few months.
The primary outcome is disability-free survival, which is an umbrella outcome that covers the effects of all major diseases including the aging process itself.
Trial Details
Population: Nearly 10,000 community-dwelling adults aged 70 and older without a prior history of cardiovascular disease, diabetes, or dementia.
Method: Participants are randomly assigned to take either 40 mg of atorvastatin or a placebo daily.
Goals: The study evaluates co-primary outcomes of prolonging disability-free survival (living without dementia or physical dependency) and reducing major cardiovascular events (heart attacks, strokes, and cardiovascular death).
Current Status: The active intervention and follow-up phase of the trial have concluded, and the data is being prepared for analysis. The primary results are expected in the second half of 2026.
Note: The researchers have purposely chosen atorvastatin for this study because of its ability to cross the blood brain barrier and potentially protect the brain. And because of its ability to easily get inside other kinds of tissue (such as early stage cancers). It is lipophilic, unlike many other statins.
Quoted:
“Statins in Reducing Events in the Elderly (STAREE) will be the first randomised controlled trial (RCT) of statin therapy in an apparently healthy cohort of older adults living independently in the community and will provide the evidence required to determine whether statin therapy should be taken routinely by healthy people aged 70 years and over.”
“Questions about statins that need answering with specific reference to older adults:
- Can statins prevent a first heart attack or stroke?
- Can statins prevent dementia?
- Can statins improve healthy life expectancy?
- Do statins impact on day to day physical function?
- Are the frequency and/or severity of adverse reactions to statins higher?
- Is the risk of developing diabetes higher?
- Is statin therapy cost effective in healthy older individuals?”
#statinsHD #statinsdementiaHD #statinselderlyHD #stareeHD #elderlyHD #dementiaHD #alzheimersHD #mortalityHD #agingHD #longevityHD #atorvastatinHD